Finanznachrichten

Galderma Announces Triple Approval of New State-of-the-Art Restylane Syringe in the EU, the U.S., and Canada, Reaffirming the Company's Position at the Forefront of Injectable ...

Regulatory authorities in the European Union (EU), the United States (U.S.), and Canada have approved a new state-of-the-art Restylane syringe for use with a range of Restylane NASHA lidocaine ...
Pharmabiz

EU, US and Canada approves Galderma’s new state-of-the-art Restylane syringe

Galderma, the pure-play dermatology category leader, announced that regulatory authorities in the EU, the US, and Canada have approved a new state-of-the-art syringe for use with its NASHA lidocaine ...
Yahoo Finance

Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of ...

Developed in collaboration with aesthetic practitioners, its innovative ergonomic design features a cushioned finger grip and thumb rest, to improve practitioner experience through better injection ...
Morningstar

Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of ...

Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-art syringe for use with its NASHA® lidocaine range of Restylane ...
The Bakersfield Californian

Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.